IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $83,000 | -63.3% | 8,616 | +77.0% | 0.01% | 0.0% |
| Q4 2020 | $226,000 | +41.2% | 4,869 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $160,000 | -70.3% | 4,869 | -75.2% | 0.00% | -66.7% |
| Q2 2020 | $539,000 | -10.5% | 19,627 | -2.5% | 0.01% | -14.3% |
| Q1 2020 | $602,000 | -14.6% | 20,121 | -21.0% | 0.01% | -12.5% |
| Q4 2019 | $705,000 | +95.8% | 25,473 | -32.7% | 0.02% | +100.0% |
| Q1 2019 | $360,000 | +7.5% | 37,870 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $335,000 | +6.7% | 37,870 | +35.6% | 0.01% | +14.3% |
| Q3 2018 | $314,000 | – | 27,937 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |